UDPG and Lung Cancer Metastasis: Unraveling the Relationship
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgVcAWqWk1FG8T3g_KC5fm5SD2LwwffAP2tlwy7BykgWjpRMK786zvVY_BMtU0g-5OqhxW-2Ya2g5gt_7meG7zWuffafX2fw0MJ2YD3eNlvCRmc4Y3uQfTCMOIZHsbbQx-HBwOgDbQ4uc_B5zMAc7t0PGneRTsY5f6h6Zgv9KvhQaEayX4fdlnMdmxQRCsy/w640-h362/Study-Finds-UDPG-promising-target-for-lung-cancer-metastasis-detection-and-Treatment.jpg)
Lung cancer is one of the malignant tumors with fast-growing morbidity and mortality and the worst prognosis. The development of molecular biology and cell biology provides targets for the prevention and treatment of lung cancer and opens up new areas for the development of drugs and methods to treat lung cancer. Metastasis is the spread of cancer cells from the primary tumor to other parts of the body. It is a significant challenge in the treatment of cancer, as it often leads to poor patient outcomes. Therefore, identifying targets that can effectively inhibit or disrupt the metastatic process is crucial for developing new therapeutic strategies. Lung cancer, like other solid tumors, is more prone to early invasion and metastasis. Uridine diphosphate glucose (UDP-Glc) is an important intermediate in glycogen synthesis and is involved in many biological processes, Preclinical studies have found that in vivo application of UDPG in rats promotes intrinsic repair potential to immat